根据脂肪肝指数或超声学定义的MAFLD对功能下降在一般人群中的影响
Yu-Ji Lee1, Kwang Min Kim2, Nak Gyeong Ko3
1Division of Nephrology, Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, 158, Paryong-ro, Masanhoewon-gu, Changwon, 51353, Republic of Korea. yuji.lee@samsung.com.
Scientific reports
|September 11, 2024
概括
通过脂肪肝指数 (FLI) 识别的代谢功能障碍相关的脂肪肝疾病 (MAFLD) 显著加快了功能下降. 超声波定义的MAFLD与功能减弱的关联较弱.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
背景情况:
- 与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 是一个日益严重的健康问题.
- MAFLD对功能下降的影响需要进一步调查.
- 不同的MAFLD诊断方法可能产生不同的临床关联.
研究的目的:
- 为了确定由脂肪肝指数 (FLI) 定义的MAFLD是否会影响功能下降.
- 评估通过超声波 (USG) 诊断的MAFLD是否与功能下降有类似的关联.
- 评估FLI定义的MAFLD与功能迅速下降之间的关系.
主要方法:
- 一项回顾性队列研究,使用了从2002年至2018年的非识别健康检查数据.
- 暴露:由FLI (初级) 和USG (二级) 定义的MAFLD.
- 结果:估计的膜过率 (eGFR) 的5年斜率和快速下降 (eGFR斜率<-3 mL/min/1.73 m2/year).
主要成果:
- FLI定义的MAFLD与5年eGFR斜率 (β = -0.11) 的显著较大的下降有关.
- 患有FLI定义的MAFLD的参与者患功能迅速衰退的风险高1.33倍 (OR = 1.33).
- 根据USG定义的MAFLD与功能下降的关系不太明显.
结论:
- 根据FLI定义的MAFLD独立地与加速的功能下降有关.
- 对MAFLD的诊断标准影响其与功能观察到的关联.
- 早期识别和管理FLI定义的MAFLD可能对保持脏健康至关重要.
更多相关视频
相关概念视频
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
82
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
82
01:17Factors Affecting Renal Clearance: Renal Impairment
62
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
62
01:11Renal Failure: Dose Adjustments
68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
01:21External Anatomy of the Kidney
872
The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
872